| Human LocusID |
Mouse ortholog LocusID | Human Gene Symbol |
Phenotype | OMIM | GI | Human Chromosomal Position |
Human Gene Name (Disease Name) |
|---|---|---|---|---|---|---|---|
| 158 | 11564 | ADSL | Adenylosuccinase deficiency | 103050 | 7 | 22q13.2 | adenylosuccinate lyase |
| 189 | 11611 | AGXT | Hyperoxaluria, primary, type 1 | 604285 | 7 | 2q36-q37 | alanine-glyoxylate aminotransferase (oxalosis I; hyperoxaluria I; glycolicaciduria; serine-pyruvate aminotransferase) |
| 190 | 11614 | NR0B1 | Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism | 300200 | 3 | Xp21.3-p21.2 | nuclear receptor subfamily 0, group B, member 1 |
| 265 | 11704 | AMELX | Amelogenesis imperfecta | 300391 | 3 | Xp22.31-p22.1 | amelogenin (X chromosome, amelogenesis imperfecta 1) |
| 268 | 11705 | AMH | Persistent Mullerian duct syndrome, type I | 600957 | 3 | 19p13.3 | anti-Mullerian hormone |
| 269 | 110542 | AMHR2 | Persistent Mullerian duct syndrome, type II | 600956 | 5 | 12q13 | anti-Mullerian hormone receptor, type II |
| 326 | 11634 | AIRE | Autoimmune polyglandular disease, type I | 240300 | 11 | 21q22.3 | autoimmune regulator (automimmune polyendocrinopathy candidiasis ectodermal dystrophy) |
| 336 | 11807 | APOA2 | Apolipoprotein A-II deficiency | 107670 | 7 | 1q21-q23 | apolipoprotein A-II |
| 344 | 11813 | APOC2 | Hyperlipoproteinemia, type Ib | 207750 | 6 | 19q13.2 | apolipoprotein C-II |
| 345 | 11814 | APOC3 | Hypertriglyceridemia | 107720 | 10 | 11q23.1-q23.2 | apolipoprotein C-III |
| 383 | 11846 | ARG1 | Argininemia | 207800 | 5 | 6q23 | arginase, liver |
| 412 | 20905 | STS | Ichthyosis, X-linked | 308100 | 2 | Xp22.32 | steroid sulfatase (microsomal), arylsulfatase C, isozyme S |
| 445 | 11898 | ASS | Citrullinemia | 603470 | 6 | 9q34.1 | argininosuccinate synthetase |
| 472 | 11920 | ATM | T-cell prolymphocytic leukemia, sporadic | 208900 | 11 | 11q22-q23 | ataxia telangiectasia mutated (includes complementation groups A, C and D) |
| 567 | 12010 | B2M | Hemodialysis-related amyloidosis | 109700 | 4 | 15q21-q22.2 | beta-2-microglobulin |
| 602 | 12051 | BCL3 | Leukemia/lymphoma, B-cell, 3 | 109560 | 4 | 19q13.1-q13.2 | B-cell CLL/lymphoma 3 |
| 641 | 12144 | BLM | Bloom syndrome | 604610 | 2 | 15q26.1 | Bloom syndrome |
| 668 | 26927 | FOXL2 | Blepharophimosis, epicanthus inversus, and ptosis, type 2 | 605597 | 2 | 3q23 | forkhead box L2 |
| 675 | 12190 | BRCA2 | Pancreatic cancer | 600185 | 5 | 13q12.3 | breast cancer 2, early onset |
| 710 | 12258 | SERPING1 | Angioedema, hereditary | 606860 | 11 | 11q12-q13.1 | serine (or cysteine) proteinase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary) |
| 714 | 12262 | C1QG | C1q deficiency, type C | 120575 | 2 | 1p36.11 | complement component 1, q subcomponent, gamma polypeptide |
| 717 | 12263 | C2 | C2 deficiency | 217000 | 8 | 6p21.3 | complement component 2 |
| 730 | 109828 | C7 | C7 deficiency | 217070 | 2 | 5p13 | complement component 7 |
| 735 | 12279 | C9 | C9 deficiency | 120940 | 5 | 5p14-p12 | complement component 9 |
| 796 | 12310 | CALCA | Osteoporosis | 114130 | 9 | 11p15.2-p15.1 | calcitonin/calcitonin-related polypeptide, alpha |
| 916 | 12501 | CD3E | Immunodeficiency, T-cell receptor/CD3 complex | 186830 | 3 | 11q23 | CD3E antigen, epsilon polypeptide (TiT3 complex) |
| 917 | 12502 | CD3G | Immunodeficiency due to defect in CD3-gamma | 186740 | 3 | 11q23 | CD3G antigen, gamma polypeptide (TiT3 complex) |
| 959 | 21947 | TNFSF5 | Immunodeficiency, X-linked, with hyper-IgM | 300386 | 6 | Xq26 | tumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome) |
| 966 | 12509 | CD59 | CD59 deficiency | 107271 | 7 | 11p13 | CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344) |
| 1028 | 12577 | CDKN1C | Beckwith-Wiedemann syndrome | 600856 | 5 | 11p15.5 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| 1029 | 12578 | CDKN2A | Pancreatic cancer/melanoma syndrome | 600160 | 16 | 9p21 | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
| 1261 | 12790 | CNGA3 | Achromatopsia-2 | 600053 | 3 | 2q11.2 | cyclic nucleotide gated channel alpha 3 |
| 1298 | 12840 | COL9A2 | Intervertebral disc disease, susceptibility to | 600204 | 4 | 1p33-p32 | collagen, type IX, alpha 2 |
| 1300 | 12813 | COL10A1 | Spondylometaphyseal dysplasia, Japanese type | 120110 | 9 | 6q21-q22 | collagen, type X, alpha 1(Schmid metaphyseal chondrodysplasia) |
| 1371 | 12892 | CPO | Harderoporphyrinuria | 121300 | 5 | 3q12 | coproporphyrinogen oxidase (coproporphyria, harderoporphyria) |
| 1392 | 12918 | CRH | ACTH deficiency | 122560 | 3 | 8q13 | corticotropin releasing hormone |
| 1409 | 12954 | CRYAA | Cataract, zonular central nuclear, autosomal dominant | 123580 | 8 | 21q22.3 | crystallin, alpha A |
| 1410 | 12955 | CRYAB | Myopathy, cardioskeletal, desmin-related, with cataract | 123590 | 6 | 11q22.3-q23.1 | crystallin, alpha B |
| 1438 | 12982 | CSF2RA | Leukemia, acute myeloid, M2 type | 425000 | 11 | Xp22.32 or Yp11.3 | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
| 1439 | 12983 | CSF2RB | Pulmonary alveolar proteinosis | 138981 | 3 | 22q13.1 | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
| 1471 | 13010 | CST3 | Cerebral amyloid angiopathy | 604312 | 6 | 20p11.21 | cystatin C (amyloid angiopathy and cerebral hemorrhage) |
| 1476 | 13014 | CSTB | Epilepsy, progressive myoclonic 1 | 601145 | 6 | 21q22.3 | cystatin B (stefin B) |
| 1482 | 18091 | NKX2E | Atrial septal defect with atrioventricular conduction defects | 600584 | 4 | 5q34 | NK2 transcription factor homolog E (Drosophila) |
| *1564 | 13100 | CYP2D7P1 | 0 | 22q13 | cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 1 | ||
| 1584 | 110115 | CYP11B1 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency | 202010 | 9 | 8q21 | cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 1 |
| 1585 | 13072 | CYP11B2 | Hypoaldosteronism, congenital, due to CMO II deficiency | 124080 | 6 | 8q21-q22 | cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 2 |
| 1588 | 13075 | CYP19 | Virilization, maternal and fetal, from placental aromatase deficiency | 107910 | 10 | 15q21.1 | cytochrome P450, subfamily XIX (aromatization of androgens) |
| 1589 | 13080 | CYP21A2 | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | 201910 | 17 | 6p21.3 | cytochrome P450, subfamily XXIA (steroid 21-hydroxylase, congenital adrenal hyperplasia), polypeptide 2 |
| 1603 | 13135 | DAD1 | Temperature-sensitive apoptosis | 600243 | 6 | 14q11-q12 | defender against cell death 1 |
| 1636 | 11421 | ACE | Myocardial infarction, susceptibility to | 106180 | 5 | 17q23 | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
| 1642 | 13194 | DDB1 | Xeroderma pigmentosum, group E, subtype 2 | 600045 | 6 | 11q12-q13 | damage-specific DNA binding protein 1, 127kDa |
| 1643 | 107986 | DDB2 | Xeroderma pigmentosum, group E, DDB-negative subtype | 600811 | 3 | 11p12-p11 | damage-specific DNA binding protein 2, 48kDa |
| 1649 | 13198 | DDIT3 | Myxoid liposarcoma | 126337 | 3 | 12q13.1-q13.2 | DNA-damage-inducible transcript 3 |
| 1678 | 30058 | TIMM8A | Deafness, X-linked 1, progressive | 300356 | 4 | Xq22.1 | translocase of inner mitochondrial membrane 8 homolog A (yeast) |
| *1718 | 74754 | DHCR24 | Desmosterolosis | 606418 | 0 | 1p33-p31.1 | 24-dehydrocholesterol reductase |
| 1736 | 108025 | DKC1 | Hoyeraal-Hreidarsson syndrome | 300126 | 8 | Xq28 | dyskeratosis congenita 1, dyskerin |
| 1747 | 13393 | DLX3 | Trichodontoosseous syndrome | 600525 | 2 | 17q21 | distal-less homeo box 3 |
| 1813 | 13489 | DRD2 | Dystonia, myoclonic | 126450 | 15 | 11q23 | dopamine receptor D2 |
| 1822 | 13498 | DRPLA | Dentatorubro-pallidoluysian atrophy | 125370 | 6 | 12p13.31 | dentatorubral-pallidoluysian atrophy (atrophin-1) |
| 1834 | 13517 | DSPP | Dentinogenesis imperfecta-1 with deafness | 125485 | 3 | 4q21.3 | dentin sialophosphoprotein |
| 1839 | 15200 | DTR | Diphtheria, susceptibility to | 126150 | 3 | 5q23 | diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) |
| 1896 | 13607 | ED1 | Ectodermal dysplasia-1, anhidrotic | 305100 | 6 | Xq12-q13.1 | ectodermal dysplasia 1, anhidrotic |
| 2006 | 13717 | ELN | Cutis laxa | 130160 | 8 | 7q11.23 | elastin (supravalvular aortic stenosis, Williams-Beuren syndrome) |
| 2010 | 13726 | EMD | Emery-Dreifuss muscular dystrophy | 300384 | 6 | Xq28 | emerin (Emery-Dreifuss muscular dystrophy) |
| 2018 | 13797 | EMX2 | Schizencephaly | 600035 | 3 | 10q26.1 | empty spiracles homolog 2 (Drosophila) |
| 2022 | 13805 | ENG | Hereditary hemorrhagic telangiectasia-1 | 131195 | 6 | 9q33-q34.1 | endoglin (Osler-Rendu-Weber syndrome 1) |
| 2122 | 14013 | EVI1 | 3q21q26 syndrome | 165215 | 1 | 3q24-q28 | ecotropic viral integration site 1 |
| 2130 | 14030 | EWSR1 | Neuroepithelioma | 133450 | 7 | 22q12.2 | Ewing sarcoma breakpoint region 1 |
| 2147 | 14061 | F2 | Hyperprothrombinemia | 176930 | 5 | 11p11-q12 | coagulation factor II (thrombin) |
| 2159 | 14058 | F10 | Factor X deficiency | 227600 | 8 | 13q34 | coagulation factor X |
| 2184 | 14085 | FAH | Tyrosinemia, type I | 276700 | 4 | 15q23-q25 | fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| 2189 | 60534 | FANCG | Fanconi anemia, complementation group G | 602956 | 5 | 9p13 | Fanconi anemia, complementation group G |
| 2243 | 14161 | FGA | Afibrinogenemia | 134820 | 10 | 4q28 | fibrinogen, A alpha polypeptide |
| 2395 | 14297 | FRDA | Friedreich ataxia with retained reflexes | 606829 | 3 | 9q13-q21.1 | Friedreich ataxia |
| 2532 | 13349 | FY | Vivax malaria, susceptibility to | 110700 | 5 | 1q21-q22 | Duffy blood group |
| 2643 | 14528 | GCH1 | Phenylketonuria, atypical, due to GCH1 deficiency | 600225 | 9 | 14q22.1-q22.2 | GTP cyclohydrolase 1 (dopa-responsive dystonia) |
| 2645 | 14635 | GCK | MODY, type II | 138079 | 10 | 7p15.3-p15.1 | glucokinase (hexokinase 4, maturity onset diabetes of the young 2) |
| 2668 | 14573 | GDNF | Hirschsprung disease | 600837 | 2 | 5p13.1-p12 | glial cell derived neurotrophic factor |
| 2690 | 14600 | GHR | Laron dwarfism | 600946 | 3 | 5p13-p12 | growth hormone receptor |
| 2729 | 14629 | GCLC | Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency | 606857 | 3 | 6p12 | glutamate-cysteine ligase, catalytic subunit |
| 2760 | 14667 | GM2A | GM2-gangliosidosis, AB variant | 272750 | 10 | 5q31.3-q33.1 | GM2 ganglioside activator protein |
| 2798 | 14715 | GNRHR | Fertile eunuch syndrome | 138850 | 8 | 4q21.2 | gonadotropin-releasing hormone receptor |
| 2811 | 14723 | GP1BA | Bernard-Soulier syndrome | 231200 | 4 | 17pter-p12 | glycoprotein Ib (platelet), alpha polypeptide |
| 2812 | 14724 | GP1BB | Giant platelet disorder, isolated | 138720 | 5 | 22q11.21 | glycoprotein Ib (platelet), beta polypeptide |
| 2815 | 54368 | GP9 | Bernard-Soulier syndrome, type C | 173515 | 4 | 3q21 | glycoprotein IX (platelet) |
| 2978 | 14913 | GUCA1A | Cone dystrophy-3 | 600364 | 3 | 6p21.1 | guanylate cyclase activator 1A (retina) |
| 3053 | 15160 | SERPIND1 | Thrombophilia due to heparin cofactor II deficiency | 142360 | 5 | 22q11.21 | serine (or cysteine) proteinase inhibitor, clade D (heparin cofactor), member 1 |
| 3098 | 15275 | HK1 | Hemolytic anemia due to hexokinase deficiency | 142600 | 14 | 10q22 | hexokinase 1 |
| 3110 | 15285 | HLXB9 | Currarino syndrome | 142994 | 2 | 7q36 | homeo box HB9 |
| 3172 | 15378 | HNF4A | MODY, type I | 600281 | 4 | 20q12-q13.1 | hepatocyte nuclear factor 4, alpha |
| 3195 | 21908 | TLX1 | Leukemia, T-cell acute lymphocytic | 186770 | 5 | 10q24 | T-cell leukemia, homeobox 1 |
| 3240 | 15439 | HP | Hypohaptoglobinemia | 140100 | 7 | 16q22.1 | haptoglobin |
| 3242 | 15445 | HPD | Tyrosinemia, type III | 276710 | 5 | 12q24-qter | 4-hydroxyphenylpyruvate dioxygenase |
| 3291 | 15484 | HSD11B2 | Apparent mineralocorticoid excess, hypertension due to | 218030 | 4 | 16q22 | hydroxysteroid (11-beta) dehydrogenase 2 |
| 3426 | 12630 | IF | C3b inactivator deficiency | 217030 | 3 | 4q25 | I factor (complement) |
| 3439 | 15962 | IFNA1 | Interferon, alpha, deficiency | 147660 | 6 | 9p22 | interferon, alpha 1 |
| 3458 | 15978 | IFNG | Interferon, immune, deficiency | 147570 | 4 | 12q14 | interferon, gamma |
| 3558 | 16183 | IL2 | Severe combined immunodeficiency due to IL2 deficiency | 147680 | 7 | 4q26-q27 | interleukin 2 |
| 3561 | 16186 | IL2RG | Combined immunodeficiency, X-linked, moderate | 308380 | 5 | Xq13.1 | interleukin 2 receptor, gamma (severe combined immunodeficiency) |
| 3594 | 16161 | IL12RB1 | Mycobacterial and salmonella infections, susceptibility to | 601604 | 2 | 19p13.1 | interleukin 12 receptor, beta 1 |
| 3630 | 16334 | INS | MODY, one form | 176730 | 7 | 11p15.5 | insulin |
| 3659 | 16362 | IRF1 | Gastric cancer | 147575 | 4 | 5q31.1 | interferon regulatory factor 1 |
| 3732 | KAI1 | Prostate cancer, susceptibility to | 600623 | 5 | 11p11.2 | kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) | |
| 3918 | 16782 | LAMC2 | Epidermolysis bullosa, generalized atrophic benign | 150292 | 7 | 1q25-q31 | laminin, gamma 2 |
| 3972 | 16866 | LHB | ?Male pseudohermaphroditism due to defective LH | 152780 | 2 | 19q13.32 | luteinizing hormone beta polypeptide |
| 4014 | 16939 | LOR | Erythrokeratoderma, progressive symmetric | 152445 | 4 | 1q21 | loricrin |
| 4056 | 17001 | LTC4S | Leukotriene C4 synthase deficiency | 246530 | 5 | 5q35 | leukotriene C4 synthase |
| 4192 | 17242 | MDK | 162096 | 5 | 11p11.2 | midkine (neurite growth-promoting factor 2) | |
| 4197 | 17251 | MDS1 | Myelodysplasia syndrome-1 | 600049 | 3 | 3q26 | myelodysplasia syndrome 1 |
| 4221 | 17283 | MEN1 | Parathyroid adenoma, sporadic | 131100 | 18 | 11q13 | multiple endocrine neoplasia I |
| 4256 | 17313 | MGP | Keutel syndrome | 154870 | 6 | 12p13.1-p12.3 | matrix Gla protein |
| 4281 | 17318 | MID1 | Opitz G syndrome, type I | 300000 | 13 | Xp22 | midline 1 (Opitz/BBB syndrome) |
| 4337 | 56738 | MOCS1 | Molybdenum cofactor deficiency, type A | 603707 | 3 | 6p21.3 | molybdenum cofactor synthesis 1 |
| 4594 | 17850 | MUT | Methylmalonicaciduria, mutase deficiency type | 251000 | 3 | 6p21 | methylmalonyl Coenzyme A mutase |
| 4601 | 17859 | MXI1 | Neurofibrosarcoma | 600020 | 7 | 10q24-q25 | MAX interacting protein 1 |
| 4693 | 17986 | NDP | Norrie disease | 310600 | 4 | Xp11.4 | Norrie disease (pseudoglioma) |
| 4867 | 53885 | NPHP1 | Nephronophthisis, juvenile | 256100 | 4 | 2q13 | nephronophthisis 1 (juvenile) |
| 4868 | 54631 | NPHS1 | Nephrosis-1, congenital, Finnish type | 602716 | 2 | 19q13.1 | nephrosis 1, congenital, Finnish type (nephrin) |
| 4942 | 18242 | OAT | Gyrate atrophy of choroid and retina with ornithinemia, B6 responsive or unresponsive | 258870 | 8 | 10q26 | ornithine aminotransferase (gyrate atrophy) |
| 5048 | 18472 | PAFAH1B1 | Lissencephaly-1 | 601545 | 5 | 17p13.3 | platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa |
| 5053 | 18478 | PAH | Phenylketonuria | 261600 | 6 | 12q22-q24.2 | phenylalanine hydroxylase |
| 5071 | 50873 | PARK2 | Parkinson disease, juvenile, type 2 | 602544 | 4 | 6q25.2-q27 | Parkinson disease (autosomal recessive, juvenile) 2, parkin |
| 5155 | 18591 | PDGFB | Dermatofibrosarcoma protuberans | 190040 | 18 | 22q13.1 | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) |
| 5199 | 18636 | PFC | Properdin deficiency, X-linked | 300383 | 8 | Xp11.3-p11.23 | properdin P factor, complement |
| 5264 | 16922 | PHYH | Refsum disease | 602026 | 4 | 10pter-p11.2 | phytanoyl-CoA hydroxylase (Refsum disease) |
| 5308 | 18741 | PITX2 | Rieger syndrome | 601542 | 3 | 4q25-q27 | paired-like homeodomain transcription factor 2 |
| 5309 | 18742 | PITX3 | Anterior segment mesenchymal dysgenesis and cataract | 602669 | 2 | 10q25 | paired-like homeodomain transcription factor 3 |
| 5320 | 18780 | PLA2G2A | ?Colorectal cancer, resistance to | 172411 | 4 | 1p35 | phospholipase A2, group IIA (platelets, synovial fluid) |
| 5449 | 18736 | POU1F1 | Pituitary hormone deficiency, combined | 173110 | 6 | 3p11 | POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1) |
| 5621 | 19122 | PRNP | Huntington disease-like 1 | 176640 | 7 | 20pter-p12 | prion protein (p27-30) (Creutzfeld-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) |
| 5625 | 19125 | PRODH | 606810 | 6 | 22q11.21 | proline dehydrogenase (oxidase) 1 | |
| 5626 | 19127 | PROP1 | Pituitary hormone deficiency, combined | 601538 | 4 | 5q35.2 | prophet of Pit1, paired-like homeodomain transcription factor |
| 5727 | 19206 | PTCH | Holoprosencephaly-7 | 601309 | 3 | 9q22.3 | patched homolog (Drosophila) |
| 5741 | 19226 | PTH | Hypoparathyroidism, autosomal recessive | 168450 | 3 | 11p15.3-p15.1 | parathyroid hormone |
| 5782 | 19248 | PTPN12 | Colon cancer | 600079 | 6 | 7q11.23 | protein tyrosine phosphatase, non-receptor type 12 |
| 5828 | 19302 | PXMP3 | Refsum disease, infantile form | 170993 | 6 | 8q21.1 | peroxisomal membrane protein 3, 35kDa (Zellweger syndrome) |
| 5921 | 110008 | RASA1 | Basal cell carcinoma | 139150 | 4 | 5q13.3 | RAS p21 protein activator (GTPase activating protein) 1 |
| 5994 | 170767 | RFXAP | Bare lymphocyte syndrome, type II, complementation group D | 601861 | 3 | 13q14 | regulatory factor X-associated protein |
| *6023 | 19782 | RMRP | Metaphyseal dysplasia without hypotrichosis | 157660 | 0 | 9p21-p12 | RNA component of mitochondrial RNA processing endoribonuclease |
| 6094 | 19881 | ROM1 | Retinitis pigmentosa, digenic | 180721 | 4 | 11q13 | retinal outer segment membrane protein 1 |
| 6247 | 20147 | RS1 | Retinoschisis | 312700 | 2 | Xp22.2-p22.1 | retinoschisis (X-linked, juvenile) 1 |
| 6324 | 20266 | SCN1B | Generalized epilepsy with febrile seizures plus | 600235 | 4 | 19q13.1 | sodium channel, voltage-gated, type I, beta polypeptide |
| 6387 | 20315 | CXCL12 | AIDS, resistance to | 600835 | 5 | 10q11.1 | chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) |
| 6401 | 20339 | SELE | Atherosclerosis, susceptibility to | 131210 | 5 | 1q22-q25 | selectin E (endothelial adhesion molecule 1) |
| 6439 | 20388 | SFTPB | Pulmonary alveolar proteinosis, congenital | 178640 | 5 | 2p12-p11.2 | surfactant, pulmonary-associated protein B |
| 6606 | 20595 | SMN1 | Spinal muscular atrophy-3 | 600354 | 8 | 5q13 | survival of motor neuron 1, telomeric |
| 6622 | 20617 | SNCA | Parkinson disease, familial | 163890 | 6 | 4q21 | synuclein, alpha (non A4 component of amyloid precursor) |
| 6716 | 94224 | SRD5A2 | Pseudovaginal perineoscrotal hypospadias | 264600 | 2 | 2p23 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
| 6886 | 21349 | TAL1 | Leukemia-1, T-cell acute lymphocytic | 187040 | 5 | 1p32 | T-cell acute lymphocytic leukemia 1 |
| 6887 | 21350 | TAL2 | Leukemia-2, T-cell acute lymphoblastic | 186855 | 3 | 9q32 | T-cell acute lymphocytic leukemia 2 |
| 6915 | 21390 | TBXA2R | Bleeding disorder due to defective thromboxane A2 receptor | 188070 | 6 | 19p13.3 | thromboxane A2 receptor |
| 6948 | 21452 | TCN2 | Transcobalamin II deficiency | 275350 | 5 | 22q12.2 | transcobalamin II; macrocytic anemia |
| 7054 | 21823 | TH | Segawa syndrome, recessive | 191290 | 4 | 11p15.5 | tyrosine hydroxylase |
| 7080 | 21869 | TITF1 | Goiter, familial, due to TTF-1 defect | 600635 | 5 | 14q13 | thyroid transcription factor 1 |
| 7139 | 21956 | TNNT2 | Cardiomyopathy, familial hypertrophic, 2 | 191045 | 9 | 1q32 | troponin T2, cardiac |
| 7178 | 108101 | TPT1 | 600763 | 3 | 13q12-q14 | tumor protein, translationally-controlled 1 | |
| 7200 | 22044 | TRH | Thyrotropin-releasing hormone deficiency | 275120 | 2 | 3q13.3-q21 | thyrotropin-releasing hormone |
| 7249 | 22084 | TSC2 | Lymphangioleiomyomatosis, somatic | 191092 | 8 | 16p13.3 | tuberous sclerosis 2 |
| 7252 | 22094 | TSHB | Hypothyroidism, nongoitrous | 188540 | 5 | 1p13 | thyroid stimulating hormone, beta |
| 7291 | 22160 | TWIST | Saethre-Chotzen syndrome with eyelid anomalies | 601622 | 6 | 7p21.2 | twist homolog (acrocephalosyndactyly 3; Saethre-Chotzen syndrome) (Drosophila) |
| 7305 | 22177 | TYROBP | Polycystic lipomembranous osteodysplasia with sclerosing leukenencephalophathy | 604142 | 4 | 19q13.1 | TYRO protein tyrosine kinase binding protein |
| *7377 | 22262 | UOX | Urate oxidase deficiency | 191540 | 0 | 1p22 | urate oxidase |
| 7390 | 22276 | UROS | Porphyria, congenital erythropoietic | 606938 | 4 | 10q25.2-q26.3 | uroporphyrinogen III synthase (congenital erythropoietic porphyria) |
| 7428 | 22346 | VHL | von Hippel-Lindau syndrome | 193300 | 2 | 3p26-p25 | von Hippel-Lindau syndrome |
| 7454 | 22376 | WAS | Thrombocytopenia, X-linked, intermittent | 300392 | 6 | Xp11.4-p11.21 | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) |
| 7466 | 22393 | WFS1 | Hearing loss, low-frequency sensorineural | 606201 | 3 | 4p16 | Wolfram syndrome 1 (wolframin) |
| 7490 | 22431 | WT1 | 194070 | 11 | 11p13 | Wilms tumor 1 | |
| *7503 | 22438 | XIST | 314670 | 0 | Xq13.2 | X (inactive)-specific transcript | |
| *7809 | 140475 | Bartter syndrome, infantile, with sensorineural deafness | 606412 | 0 | 1p32.1 | barttin | |
| 7957 | 13853 | EPM2A | Epilepsy, myoclonic, Lafora type | 254780 | 6 | 6q24 | epilepsy, progressive myoclonus type 2, Lafora disease (laforin) |
| 8074 | 64654 | FGF23 | Osteomalacia, tumor-induced | 605380 | 4 | 12p13.3 | fibroblast growth factor 23 |
| 8091 | 15364 | HMGA2 | Uterine leiomyoma | 600698 | 6 | 12q15 | high mobility group AT-hook 2 |
| 8115 | 21432 | TCL1A | Leukemia/lymphoma, T-cell | 186960 | 4 | 14q32.1 | T-cell leukemia/lymphoma 1A |
| 8292 | 12844 | COLQ | Endplate acetylcholinesterase deficiency | 603033 | 13 | 3p25 | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
| 8481 | 52045 | OFD1 | Oral-facial-digital syndrome 1 | 300170 | 3 | Xp22.2-p22.3 | oral-facial-digital syndrome 1 |
| 9241 | 18121 | NOG | Tarsal-carpal coalition syndrome | 602991 | 2 | 17q22 | noggin |
| 10216 | 65022 | PRG4 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | 604283 | 2 | 1q25-q31 | proteoglycan 4, (megakaryocyte stimulating factor, articular superficial zone protein, camptodactyly, arthropathy, coxa vara, pericarditis syndrome) |
| *89781 | 192232 | HPS4 | Hermansky-Pudlak syndrome | 606682 | 0 | 22cen-q12.3 | Hermansky-Pudlak syndrome 4 |
| *117156 | 117158 | SCGB3A2 | Asthma, susceptibility to | 606531 | 0 | 5q32 | secretoglobin, family 3A, member 2 |
| 117531 | 13409 | TMC1 | Deafness, autosomal recessive 7 | 606706 | 2 | 9q21.12 | transmembrane cochlear-expressed gene 1 |
| 170302 | 11878 | ARX | Myoclonic epilepsy, X-linked, with mental retardation and spasticity | 300382 | 1 | Xp22.12 | aristaless related homeobox |